Your search for ‘Fulbright & Jaworski LLP’ returned 961 results

Bill C-17, An Act to Amend the Food and Drugs Act (also referred to as the Protecting Canadians from Unsafe Drugs Act), received Royal Assent on November 6, 2014.

The expansion of research in genetics, genomics and other personalized healthcare approaches has allowed physicians to customize medical treatment.

This case dealt with an appeal by Apotex Inc. (Apotex) from a decision of Justice Gauthier in T-156-05 and T-787-05 which dismissed Apotex’s motion to set aside an order granted to Eli Lilly Canada Inc.

This update discusses the new standards requiring biometrics to be given by citizens of certain countries who apply for a temporary resident visa in order to visit, study or work in Canada.

The Saskatchewan government has set the stage for significant changes to insurance regulation in the province with the enactment of The Insurance Act on May 14, 2015.

The Federal Court has granted a limited permanent injunction to AbbVie against Janssen Inc. ("Janssen") preventing certain marketing activities in respect of the sale of STELARA® in Canada.

The Federal Court of Appeal allowed Janssen’s appeals of three decisions of Mr. Justice Hughes that resulted in an injunction order against Janssen following a finding that AbbVie’s patent was valid and infringed.

Depuis déjà trois jours, l’industrie de la construction est en grève générale illimitée partout au Québec.

The OSC and regulators in six other provinces published for comment proposed prospectus exemptions for issuers seeking to use crowdfunding to raise capital.

Amendments to Part II of the Canada Labour Code are set to take effect as of October 31, 2014.

Je vous présente aujourd'hui un second billet signé Geneviève Hallé-Désilets, stagiaire au bureau de Québec, dans lequel Geneviève s'intéresse tout particulièrement aux brevets dans le secteur de la mode.

The BC Court of Appeal holds that the duty to consult must focus on novel impacts of Crown approval for a project—not past wrongs—and also holds that the Crown may take an incremental partial approach to consultation where an industry actor is seeking individual permit approvals in the context of a larger project.

In a ruling by the Quebec Court of Appeal in September 2013, one of the issues before the Court was whether an employee could be awarded non-monetary damages on account of alleged wrongful conduct by the employer when it did not renew her contract of employment.

This was a decision of the Trade-marks Opposition Board (TMOB or the Board) respecting the likelihood of confusion between the applicant's mark AMPRIVA and the opponent's mark APIDRA®.

The action was dismissed against two of five makers of fentanyl transdermal patches—Teva Canada Limited and Sandoz Canada Incorporated.

In proceedings pursuant to the Companies’ Creditors Arrangement Act concerning The Cash Store Financial Services et al., the Court of Appeal for Ontario dismissed an appeal from a decision of the Superior Court of Justice (Commercial List).

When a foreign court issues a request for assistance to Canadian judicial authorities, what should a Canadian court do?

A discussion on whether a Canadian parent company with a subsidiary operating in a foreign jurisdiction can be liable for human rights violations in the foreign jurisdiction that occur at the level of the subsidiary.